dengu
virus
denv
envelop
singlestrand
positivesens
rna
virus
transmit
aed
spp
mosquito
four
genet
distinct
serotyp
design
subdivid
distinct
genotyp
dengu
scientif
commun
long
contend
infect
one
serotyp
confer
lifelong
protect
subsequ
infect
serotyp
irrespect
viru
genotyp
howev
hypothesi
increas
scrutini
role
denv
genotyp
variat
protect
repeat
infect
less
certain
dengu
vaccin
trial
move
increasingli
fieldtest
urgent
need
develop
tool
better
defin
role
genotyp
variat
denv
infect
immun
better
understand
genotyp
variat
neutral
protect
design
construct
panel
isogen
recombin
infecti
clone
express
envelop
glycoprotein
differ
genotyp
philippin
genotyp
thailand
genotyp
ii
sri
lanka
cuba
genotyp
iii
puerto
rico
genotyp
iv
use
panel
explor
natur
envelop
variat
influenc
denvpolyclon
serum
interact
recombin
virus
test
neutral
assay
use
immun
sera
primari
denv
infect
neutral
titer
vari
much
depend
express
envelop
glycoprotein
observ
variabl
neutral
titer
suggest
rel
residu
chang
e
glycoprotein
may
signific
effect
denv
specif
humor
immun
influenc
antibodi
mediat
protect
diseas
enhanc
set
natur
infect
vaccin
genotyp
differ
also
like
import
tempor
spatial
microevolut
background
heterotyp
neutral
recombin
synthet
tool
describ
valuabl
test
hypothes
genet
determin
immunopathogenesi
dengu
viru
denv
envelop
rna
viru
famili
flavivirida
genu
flaviviru
transmit
bite
aed
spp
mosquito
denv
occur
throughout
tropic
subtrop
infect
approxim
million
individu
annual
four
distinct
serotyp
prospect
studi
found
infect
asymptomat
proport
infect
person
develop
symptom
includ
fever
rash
myalgia
less
develop
sever
diseas
syndrom
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
character
hemorrhag
vascular
leakag
hypovolemia
untreat
shock
end
organ
failur
death
approxim
person
die
annual
dhf
dhfdss
classic
associ
secondari
infect
occur
context
preexist
heterotyp
immun
lead
hypothes
dhfdss
immun
mediat
phenomenon
driven
crossreact
denv
antibodi
andor
denv
specif
tcell
review
see
viru
genotyp
also
clearli
play
import
role
sever
diseas
pathogenesi
multipl
studi
denv
molecular
epidemiolog
found
associ
circul
viru
genotyp
diseas
sever
howev
genet
basi
virul
differ
deciph
one
fundament
barrier
denv
vaccin
develop
concern
denv
vaccin
must
broadli
protect
four
serotyp
recipi
risk
secondarylik
infect
sever
diseas
associ
natur
acquir
secondari
infect
vaccin
trial
assess
protect
four
serotyp
use
prototyp
vaccin
relat
viru
isol
studi
need
address
degre
intraserotyp
genotyp
differ
may
affect
antibodymedi
immun
denv
serotyp
includ
genotyp
specif
genet
differ
scatter
across
viral
genom
envelop
glycoprotein
e
main
target
neutral
human
antibodi
one
logic
first
choic
assess
genet
basi
differenti
antibodi
mediat
neutral
infect
e
glycoprotein
exist
homodim
distinct
domain
ii
iii
matur
denv
virion
arrang
flat
herringbon
pattern
icosahedr
symmetri
domain
edi
ii
edii
linearli
discontinu
fold
form
central
eightstrand
barrel
domain
later
protrus
domain
ii
contain
highli
conserv
fusion
loop
requir
virion
fusion
endosom
domain
iii
ediii
continu
peptid
extend
domain
form
ig
like
fold
believ
ligand
yet
unidentifi
cellular
receptor
success
dengu
vaccin
induc
broadli
protect
antibodi
geograph
variant
serotyp
dengu
commun
long
held
primari
infect
one
serotyp
confer
longlast
immun
serotyp
irrespect
infect
viru
genotyp
base
princip
earli
human
challeng
trial
multipl
observ
studi
shown
within
particular
region
reinfect
serotyp
gener
occur
geograph
partit
denv
genotyp
significantli
limit
understand
role
strain
variat
protect
immun
vast
major
denv
infect
person
endem
region
never
travel
region
denv
genotyp
circul
sever
recent
find
indic
genotyp
variat
may
import
immun
recent
studi
strain
variant
use
recombin
protein
whole
viru
found
neutral
mab
rais
one
genotyp
limit
neutral
activ
heterolog
genotyp
primat
vaccin
studi
polyclon
immun
sera
also
demonstr
variabl
neutral
strain
studi
pediatr
dengu
case
thailand
investig
observ
signific
differ
abil
sera
neutral
refer
clinic
strain
recent
report
dengu
neutral
test
highlight
need
evalu
vaccin
induc
immun
respons
use
contemporari
strain
repres
differ
serotyp
genotyp
dengu
consist
four
distinct
genotyp
ii
iii
iv
origin
associ
specif
geograph
region
current
genotyp
ii
circul
asia
genotyp
iii
circul
indian
subcontin
africa
latin
america
genotyp
iv
appear
displac
occur
throughout
caribbean
describ
construct
fourfrag
infecti
clone
platform
panel
isogen
recombin
virus
captur
e
glycoprotein
genotyp
heterogen
approach
novel
flavivirus
human
coronaviru
cov
investig
use
similar
system
introduc
larg
synthes
genom
element
recombin
virus
investig
genet
variabl
cov
biolog
pathogenesi
see
exampl
cov
system
power
tool
expand
understand
genet
differ
cov
applic
flavivirus
may
prove
similarli
power
subsequ
test
isogen
recombin
virus
panel
immun
sera
peopl
expos
primari
secondari
denv
infect
data
demonstr
role
natur
epitop
variat
viru
neutral
escap
molecular
clone
also
prove
valuabl
tool
studi
varieti
aspect
biolog
pathogenesi
immunopathogenesi
epitop
map
evolut
institut
review
board
univers
north
carolina
chapel
hill
approv
protocol
recruit
collect
blood
sampl
peopl
written
inform
consent
obtain
donor
vero
cell
atcc
maintain
mem
supplement
fc
gibco
nonessenti
amino
acid
gibco
lglutamin
gibco
antianti
antibiot
mix
gibco
co
cell
atcc
maintain
mem
supplement
fc
nonessenti
amino
acid
lglutamin
antianti
co
clone
strategi
clone
illustr
figur
base
strategi
employ
cov
circumv
sequenc
instabl
problem
ecoli
clone
parent
sri
lankan
isol
genotyp
iii
design
submit
genbank
isol
subclon
revers
transcript
perform
amv
revers
transcriptas
roch
oligodeoxynucleotid
primer
accord
manufactur
recommend
use
primer
bsmbiden
follow
cdna
synthesi
cdna
amplifi
pcr
expand
long
taq
polymeras
boehring
mannheim
biochem
cycl
set
base
size
amplicon
dengu
genom
amplifi
cdna
clone
set
four
fragment
figur
text
first
fragment
pcr
amplifi
use
primer
set
den
primer
creat
rna
promot
end
fragment
bsmbi
restrict
site
end
respect
pcr
product
gel
isol
qiagen
qiaquick
gel
extract
kit
clone
pcrxl
topo
clone
vector
invitrogen
infecti
viru
clone
valuabl
tool
studi
chang
viral
genet
code
affect
viral
biolog
dengu
viru
import
mosquitoborn
viru
worldwid
yet
dengu
viru
infecti
clone
histor
challeng
make
manipul
make
difficult
studi
varieti
genet
chang
observ
dengu
virus
describ
construct
panel
five
dengu
viru
serotyp
clone
use
novel
strategi
previous
employ
dengu
research
strategi
use
genet
fragment
synthes
gene
introduc
genet
chang
minim
affect
viru
five
recombin
clone
design
express
genet
distinct
envelop
protein
deriv
strain
circul
differ
region
world
use
recombin
virus
coupl
sera
geograph
defin
human
case
studi
impact
e
variat
neutral
outcom
data
demonstr
recombin
virus
vari
significantli
neutral
outcom
depend
sera
long
presum
infect
vaccin
one
serotyp
confer
lifelong
protect
variant
serotyp
result
indic
assumpt
requir
rigor
assess
denv
commun
variabl
neutral
genotyp
wwwplosntdsorg
second
fragment
b
amplifi
use
primer
primer
introduc
bsmbi
site
allow
direct
ligat
fragment
b
figur
text
primer
introduc
silent
chang
dengu
genom
nucleotid
nt
creat
uniqu
bgli
site
without
alter
amino
acid
sequenc
fragment
c
amplifi
primer
primer
set
duplic
bgli
site
b
fragment
natur
occur
bgli
site
nt
pcr
amplicon
fragment
b
c
gel
isol
clone
pcrxl
topo
clone
vector
fragment
amplifi
primer
bsmbiden
pcr
product
went
approxim
nt
end
dengu
genom
contain
two
bgli
site
one
nt
nt
bgli
site
nt
remov
use
overlap
pcr
two
amplicon
gener
use
primer
primer
bsmbiden
respect
two
amplicon
join
overlap
extens
pcr
reaction
result
product
digest
sapi
ligat
sapi
digest
den
fragment
final
cdna
fragment
bgli
site
knock
gel
isol
clone
big
easi
linear
clone
vector
lucigen
four
six
clone
fragment
sequenc
verifi
four
den
cdna
isol
plasmid
direct
ligat
creat
fulllength
cdna
dengu
viral
genom
fulllength
cdna
contain
introduc
nucleotid
chang
silent
could
transcrib
polymeras
ambion
rna
produc
infecti
dengu
viru
electropor
vero
cell
construct
e
glycoprotein
variant
clone
figur
synthes
envelop
gene
nucleotid
dengu
genom
deliv
plasmid
bio
basic
portion
envelop
gene
need
insert
plasmid
pcr
amplifi
either
forward
revers
primer
primer
text
product
digest
bsteii
bsmbi
ligat
plasmid
digest
enzym
dengu
b
plasmid
contain
envelop
variant
gener
first
pcr
amplifi
synthet
gene
den
primer
primer
text
parent
b
fragment
primer
egen
text
product
digest
bsai
ligat
togeth
final
ligat
gel
purifi
clone
pcrxl
topo
clone
vector
replac
parent
clone
prmm
gene
genotyp
prmm
gene
rna
lab
stock
genotyp
viru
revers
transcrib
random
hexam
cdna
pcr
amplifi
primer
result
amplicon
digest
bstapi
pflmi
product
ligat
den
plasmid
correspond
indonesia
genotyp
e
gene
digest
use
enzym
result
plasmid
den
sequenc
verifi
use
construct
genotyp
recombin
viru
plasmid
transform
propag
e
coli
compet
cell
invitrogen
grown
lb
plate
select
antibiot
b
c
contain
plasmid
select
kanamycin
chloramphenicol
hour
individu
coloni
pick
screen
sequenc
plasmid
subsequ
grown
high
concentr
select
lb
plasmid
purifi
qiagen
minispin
kit
digest
follow
accord
manufactur
instruct
den
spei
neb
follow
calf
intestin
phosphotas
neb
bsmbi
neb
yield
kb
fragment
den
b
bgli
neb
bsmbi
yield
kb
fragment
den
c
bgli
yield
kb
fragment
den
bgli
bsmbi
yield
kb
fragment
fragment
gelisol
qiagen
gel
extract
kit
agaros
gel
mix
equival
copi
number
ligat
ligas
neb
overnight
fulllength
transcript
cdna
construct
gener
vitro
describ
manufactur
ambion
austin
tex
mmessag
mmachin
follow
modif
reaction
mixtur
supplement
ml
mm
gtp
stock
result
ratio
gtp
cap
analog
incub
hour
vero
cell
grown
confluenc
trypsin
resuspend
rnase
free
pb
cellsml
rna
transcript
mix
ml
vero
cell
suspens
electropor
cuvett
four
electr
puls
v
mf
given
biorad
gene
pulser
ii
electropor
transfect
vero
cell
seed
ml
flask
incub
day
two
five
ml
supernat
electropor
vero
cell
passag
day
confluent
uninfect
vero
cell
cm
flask
fresh
media
ad
final
volum
ml
seven
day
supernat
harvest
supplement
fb
clarifi
centrifug
frozen
passag
serial
amplifi
work
viru
stock
time
studi
initi
uniqu
fulllength
envelop
gene
avail
genbank
sequenc
ad
sri
lankan
sequenc
laboratori
envelop
amino
acid
sequenc
align
use
clustalx
version
one
repres
sequenc
select
genotyp
repres
sequenc
chosen
base
amino
acid
conserv
figur
design
infecti
clone
chimera
panel
provid
schemat
represent
denv
genom
divid
structur
nonstructur
gene
arrow
indic
primer
name
approxim
primer
locat
orient
genom
primer
use
amplifi
differ
cdna
fragment
well
ad
appropri
termin
restrict
enzym
recognit
sequenc
promot
locat
primer
den
primer
pair
gener
complet
fragment
align
opposit
one
anoth
clone
propag
three
circular
one
linear
plasmid
denv
fragment
within
plasmid
highlight
blue
final
fragment
assembl
gener
clone
repres
bottom
figur
blue
line
length
restrict
site
locat
approxim
support
exact
primer
sequenc
posit
pcr
fragment
size
note
text
panel
b
illustr
strategi
use
e
gene
construct
insert
top
figur
repres
den
b
fragment
encod
e
protein
arrow
indic
approxim
locat
primer
egen
use
silent
introduc
bsai
recognit
sequenc
end
fragment
den
b
bio
basic
e
construct
black
repres
synthes
e
gene
schemat
illustr
approxim
arrang
e
gene
domain
restrict
site
roman
numer
indic
e
domain
tm
transmembran
region
arrow
indic
primer
name
approxim
locat
pair
orient
use
introduc
restrict
enzym
recognit
sequenc
length
posit
shown
approxim
e
construct
amplifi
insert
den
fragment
primer
b
fragment
primer
sequenc
confirm
construct
den
b
fragment
digest
indic
enzym
desir
fragment
gel
purifi
subject
ligat
gener
new
den
den
b
fragment
contain
e
construct
type
ii
restrict
endonucleas
variabl
neutral
genotyp
wwwplosntdsorg
within
genotyp
cluster
sequenc
closest
consensu
outlier
amino
acid
select
repres
repres
sequenc
chosen
genotyp
indonesia
genbank
access
genotyp
ii
thailand
genbank
access
genotyp
iii
cuba
genbank
access
puerto
rico
pr
genbank
access
virus
use
subsequ
experi
passag
three
propag
vero
cell
passag
three
clone
sequenc
verifi
use
previous
describ
method
assess
viral
replic
kinet
clone
inocul
triplic
onto
confluent
monolay
vero
cell
well
plate
multipl
infect
moi
ffuml
cell
incub
either
vero
cell
mainten
media
condit
cell
line
minut
innocula
remov
cell
wash
twice
ml
pb
monolay
cover
total
volum
ml
media
min
ul
cell
supernat
design
day
sampl
taken
duplic
equal
volum
media
replac
sampl
supplement
fc
clarifi
centrifug
store
sampl
taken
manner
everi
addit
day
viru
titer
determin
describ
sera
collect
adult
volunt
histori
denv
infect
one
anonym
donor
dengu
infect
confirm
serolog
sampl
sera
character
flow
cytometri
unc
prnt
nih
bethesda
md
prnt
cdc
san
juan
confirm
past
exposur
primari
secondari
denv
infect
also
identifi
serotyp
respons
primari
infect
note
establish
infect
viru
genotyp
experiment
sera
neutral
pattern
alon
howev
genotyp
ii
iii
current
circul
sampl
almost
certainli
captur
genotyp
ii
thailand
iii
latin
america
base
donor
travel
histori
frnt
procedur
base
method
previous
describ
whitehead
briefli
twentyfour
well
plate
seed
vero
cell
mem
supplement
fetal
bovin
serum
fb
grown
hour
growth
media
remov
viru
titrat
viru
stock
dilut
serial
tenfold
ul
dilut
ad
individu
well
hr
incub
rocker
well
overlaid
ml
methylcellulos
optimem
gibco
supplement
fb
cellgro
antibiot
mix
gibco
antianti
plate
incub
day
co
day
overlay
remov
cell
wash
pb
fix
methanol
either
store
develop
develop
plate
fix
monolay
block
minut
instant
milk
pb
follow
incub
antiflaviviru
mab
dilut
block
buffer
hr
well
wash
pb
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
ab
sigma
dilut
block
buffer
hr
plate
wash
pb
foci
develop
addit
ul
trueblu
hrp
substrat
kpl
foci
count
light
box
viral
titer
calcul
standard
method
frnt
mab
human
sera
serial
dilut
fivefold
start
dilut
dilut
mix
approxim
focu
form
unit
ffu
viru
final
volum
ul
incub
hour
co
ad
triplic
well
plate
process
mean
focu
diamet
calcul
fociclon
measur
magnif
multipl
align
perform
use
clustalx
version
phylogenet
tree
envelop
protein
sequenc
conduct
use
mr
bay
version
huelsenbeck
jp
briefli
amino
acid
envelop
sequenc
import
clustalx
align
perform
use
default
paramet
structur
model
inform
site
gener
use
macpymol
delano
scientif
crystal
structur
envelop
pdb
mean
focu
size
compar
oneway
analysi
varianc
anova
follow
dunnett
test
multipl
comparison
growth
curv
frnt
count
enter
graphpad
prism
version
osx
graphpad
softwar
san
diego
california
usa
wwwgraphpadcom
frnt
valu
calcul
sigmoid
doserespons
curv
fit
upper
lower
limit
respect
error
bar
show
confid
interv
unless
otherwis
specifi
mean
frnt
valu
compar
oneway
anova
follow
tukey
hsd
multipl
comparison
test
signific
level
alpha
p
set
parent
clone
genotyp
iii
variant
isol
sri
lankan
df
patient
figur
see
materi
method
fulllength
flavivirus
genom
previous
describ
unstabl
toxic
tradit
e
coli
clone
system
disrupt
put
toxic
region
facilit
creation
chimer
clone
genom
clone
segment
sequenti
fragment
fragment
junction
final
platform
chosen
multipl
trial
maxim
insert
plasmid
stabil
e
coli
clone
junction
base
type
ii
restrict
enzym
site
bsmbi
bgli
figur
allow
direct
assembl
fulllength
cdna
describ
materi
method
digest
purif
individu
cdna
fulllength
cdna
assembl
invitro
ligat
transcript
electropor
cell
recombin
virus
recov
first
passag
vero
cell
cultur
supernat
sequenc
analys
verifi
indic
mutat
within
cdna
clone
fragment
nucleotid
mutat
detect
entir
genom
recombin
viru
three
passag
vero
cell
data
shown
evalu
role
e
protein
sequenc
variat
antibodi
interact
repres
e
gene
genotyp
ii
iii
iv
virus
figur
text
select
publish
sequenc
e
gene
select
repres
genotyp
whose
sequenc
close
match
consensu
e
sequenc
gener
genotyp
genotyp
indonesia
isol
genotyp
ii
thailand
isol
genotyp
iii
cuba
isol
genotyp
iv
puerto
rico
isol
total
inform
site
identifi
across
repres
genotyp
materi
method
form
variabl
neutral
genotyp
wwwplosntdsorg
nine
cluster
surfac
e
glycoprotein
rel
evenli
distribut
domain
ii
iii
text
gener
clone
would
allow
test
variabl
neutral
repres
sequenc
synthes
bio
basic
insert
parent
clone
background
replac
parent
e
gene
figur
three
four
variant
clone
success
recov
correct
replac
e
gene
alon
one
variant
howev
indonesia
genotyp
requir
replac
parent
sl
genotyp
iii
prem
gene
genotyp
premm
gene
support
earlier
studi
coevolutionari
chang
premm
may
essenti
effici
e
gene
function
select
instanc
fulllength
sequenc
passag
three
recombin
viru
clone
use
throughout
experi
found
one
nucleotid
mutat
one
five
clone
silent
c
pyrimidin
transit
mutat
genom
posit
genotyp
viru
denv
clinic
isol
reliabl
form
plaqu
vero
cell
monolay
viral
growth
vero
cell
monolay
instead
character
focu
format
see
materi
method
five
clone
form
foci
vero
cell
monolay
parent
clone
sl
iii
cuba
iii
produc
moder
size
rel
uniform
foci
growth
vero
cell
monolay
tabl
clone
indonesia
e
gene
produc
margin
smaller
foci
thailand
ii
pr
iv
foci
markedli
smaller
form
parent
clone
tabl
strike
differ
plaqu
phenotyp
underscor
import
structur
protein
basic
viral
biolog
may
due
either
e
gene
differ
viru
envelop
prme
mismatch
viru
clone
though
identifi
particular
genet
differ
caus
phenotyp
beyond
paper
scope
growth
kinet
panel
recombin
virus
character
mammalian
vero
cell
mosquito
cell
commonli
use
denv
propag
quantif
cell
line
infect
parent
clone
multipl
infect
moi
ffucel
grown
hour
vero
cell
growth
curv
parent
viru
five
clone
similar
prepar
produc
focusform
viru
hour
peak
viral
titer
achiev
hour
hour
figur
peak
log
viral
titer
rang
log
ffuml
parent
clone
log
ffuml
genotyp
ii
clone
earli
growth
slower
genotyp
indonesia
recombin
viru
ultim
reach
peak
titer
equival
recombin
growth
kinet
cell
similar
vero
cultur
except
viru
detect
hr
post
infect
figur
peak
titer
gener
similar
though
parent
clone
singl
peak
log
titer
log
ffuml
significantli
higher
viru
sampl
remain
peak
titer
rang
log
ffuml
log
ffuml
differ
significantli
genotyp
indonesia
clone
show
slower
kinet
clone
particularli
earli
infect
figur
overal
intergenotyp
e
variabl
minim
impact
virus
growth
tissu
cultur
assess
role
denv
e
glycoprotein
variat
viral
neutral
human
polyclon
sera
isogen
clone
test
panel
late
convalesc
year
human
antidenv
primari
secondari
sera
collect
individu
north
carolina
infect
foreign
travel
tabl
text
major
neutral
test
repeat
independ
experi
highli
reproduc
frnt
valu
text
origin
infect
viru
known
sera
eight
primari
serum
sampl
test
parent
isogen
recombin
virus
variabl
e
gene
differ
genotyp
text
clone
show
differenti
neutral
pattern
three
sera
figur
b
e
serum
sampl
taken
travel
acquir
primari
infect
thailand
frnt
titer
rang
iii
indonesia
text
serum
sampl
taken
travel
acquir
primari
infect
puerto
rico
calcul
frnt
similar
observ
titer
rang
low
titer
pr
iv
high
sri
sl
iii
clone
indonesia
text
serum
sampl
travel
infect
nicaragua
frnt
rang
low
pr
iv
high
thailand
ii
text
frnt
valu
consist
accept
cutoff
true
homotyp
neutral
consist
low
six
fifteen
clone
titer
group
less
text
importantli
found
significantli
variabl
neutral
profil
five
recombin
virus
neutral
five
remain
homotyp
sera
test
figur
though
serum
sampl
el
salvador
infect
neutral
five
clone
found
differ
calcul
lowest
highest
neutral
titer
low
neutral
group
consist
indonesia
pr
iv
second
high
neutral
group
includ
remain
clone
cuba
thailand
phylogenet
tree
illustr
genet
related
viru
genotyp
includ
virus
repres
e
gene
synthes
tree
meant
display
divers
includ
sequenc
use
evalu
genet
variabl
e
gene
instead
repres
sequenc
genotyp
select
inclus
tree
tree
construct
use
maximum
likelihood
method
base
tamuranei
model
tree
drawn
scale
branch
length
measur
number
substitut
per
site
analysi
involv
nucleotid
sequenc
total
posit
final
dataset
evolutionari
analys
conduct
figur
infect
india
similarli
potent
four
five
clone
titer
greater
pr
iv
recombin
viru
show
significantli
lower
neu
traliz
titer
text
sampl
figur
figur
infect
thailand
nicaragua
respect
neutral
titer
differ
five
six
fold
recombin
virus
express
thailand
pr
e
glycoprotein
text
extrem
neutral
differ
clone
seen
use
serum
figur
sri
lanka
donor
serum
titer
effici
neutral
indonesia
thailand
clone
respect
genotyp
iii
clone
neutral
much
lower
dilut
sri
lanka
cuba
text
thu
observ
signific
variat
neutral
across
genotyp
five
eight
primari
homotyp
sera
test
human
anti
denv
secondari
sera
known
broadli
neutral
across
serotyp
would
expect
show
rel
high
broad
frnt
valu
resist
intragenotyp
variabl
test
assumpt
five
clone
test
serum
patient
secondari
denv
infect
india
sri
lanka
clone
effici
neutral
rel
high
titer
though
highest
indonesia
lowest
cuba
differ
significantli
text
figur
though
differ
less
threefold
heterotyp
primari
antidenv
serum
may
lowlevel
serotypecross
neutral
activ
one
studi
shown
protect
heterotyp
infect
case
assess
role
e
glycoprotein
variat
heterotyp
crossneutr
clone
panel
test
repres
primari
sera
tabl
text
sampl
collect
primari
infect
acquir
sri
lanka
low
level
detect
frnt
rang
figur
text
serum
frnt
titer
rang
figur
text
sampl
collect
infect
hondura
similarli
scale
frnt
rang
figur
text
howev
repeat
frnt
clone
panel
homotyp
sera
yield
highli
reproduc
neutral
titer
repeat
frnt
reproduc
heterotyp
sera
text
significantli
limit
conclus
might
drawn
variabl
heterotyp
neutral
cj
lai
et
al
describ
first
fulllength
infecti
denv
clone
isol
isol
patient
dominican
republ
time
author
note
fulllength
denv
cdna
unstabl
e
coli
overcom
use
twofrag
system
divid
toxic
genom
region
subsequ
new
guinea
c
west
pacif
clone
employ
similar
fragment
base
strategi
overcom
genom
stabil
problem
though
singl
plasmid
clone
also
seen
consider
use
exampl
blaney
et
al
use
clinic
isol
sleman
describ
first
infecti
clone
though
base
fulllength
cdna
plasmid
success
propag
plasmid
dna
requir
insert
nt
linker
region
contain
termin
sequenc
forward
revers
open
read
frame
near
junction
date
parent
sleman
clone
princip
use
backbon
vaccin
candid
tabl
text
folddilut
serum
yaxi
clone
identifi
xaxi
column
show
gmt
frnt
valu
calcul
frnt
done
triplic
error
bar
indic
confid
interv
column
connect
horizont
line
indic
group
clone
statist
significantli
differ
frnt
valu
connect
bar
indic
individu
group
clone
differ
statist
tukey
hsd
sera
figur
figur
figur
clearli
instabl
toxic
principl
challeng
develop
tractabl
denv
infecti
clone
smaller
denv
cdna
subclon
platform
employ
offer
sever
advantag
individu
fragment
highli
stabl
e
coli
manipul
individu
without
affect
distant
site
genom
allow
fragment
reassort
denv
strain
type
ii
restrict
enzym
bgli
bsmbi
gener
uniqu
overhang
prevent
spuriou
selfassembl
subclon
technic
problem
palindrom
cut
restrict
enzym
final
multipl
mutat
incorpor
simultan
separ
fragment
circumv
iter
mutat
sequenc
entir
molecular
clone
allow
reassort
fragment
except
genotyp
e
gene
parent
molecular
clone
backbon
recept
heterotyp
e
sequenc
suspect
genotyp
specif
prmme
interact
genotyp
iii
parent
prmm
genotyp
e
account
failur
recov
viabl
genotyp
e
chimera
genotyp
prmm
differ
genotyp
ii
iii
iv
posit
first
histidin
lysin
mutat
prmm
posit
region
predict
form
strand
two
parallel
beta
sheet
interact
e
fusion
loop
polymorph
posit
like
explain
origin
genotyp
clone
viabl
second
differ
leucin
phenylalanin
mutat
posit
polymorph
conserv
hydrophob
charact
residu
henc
think
unlik
mutat
affect
origin
genotyp
chimera
viabil
replac
parent
prm
gene
genotyp
prm
establish
viabl
clone
argu
futur
construct
includ
prm
e
genotyp
howev
overal
clone
platform
remark
stabl
full
length
sequenc
passag
three
five
clone
found
one
silent
nucleotid
mutat
one
indonesia
five
clone
recombin
virus
grew
equival
peak
titer
compar
parent
clone
though
indonesia
show
delay
growth
kinet
cell
line
differ
plaqu
phenotyp
emerg
e
glycoprotein
chang
chimer
construct
may
affect
interact
e
nonstructur
protein
directli
chang
rnarna
interact
effect
like
subtl
given
rel
similar
clone
growth
kinet
tissu
cultur
unlik
directli
affect
chimer
clone
neutral
polyclon
sera
forti
year
ago
halstead
other
first
report
variabl
neutral
clinic
isol
observ
mous
immun
sera
rais
strain
poorli
neutral
low
passag
wildtyp
isol
thailand
author
hypothes
observ
differ
neutral
due
within
serotyp
antigen
differ
shortli
thereaft
russel
et
al
report
similar
find
human
immun
sera
found
human
convalesc
sera
mous
hyperimmun
sera
tahitian
caribbean
poorli
neutral
thailand
clinic
isol
differ
hemagglutin
inhibit
hi
titer
vari
author
argu
differ
titer
evid
genet
subtyp
within
time
novel
idea
although
genet
basi
variabl
phenotyp
unclear
author
also
argu
caribbean
strain
would
poor
vaccin
candid
antigen
properti
elicit
broadli
neutral
homotyp
antibodi
despit
earli
observ
variabl
neutral
within
serotyp
phenomenon
remain
larg
unexplor
part
tool
exist
isol
antigen
variat
otherwis
stabl
genet
background
recent
zulueta
et
al
found
human
sera
acut
genotyp
iii
infect
essenti
nonreact
recombin
genotyp
iv
ediii
appropri
reactiv
genotyp
iii
ediii
howev
studi
find
significantli
limit
use
pool
acut
human
sera
bind
assay
rather
neutral
assay
individu
human
polyclon
serum
sampl
relat
set
experi
cuban
research
test
convalesc
sera
collect
twenti
df
dhf
case
cuban
epidem
panel
six
isol
collect
sera
prnt
titer
clinic
isol
epidem
differ
nearli
patient
sera
effect
neutral
viru
epidem
howev
tabl
text
folddilut
serum
yaxi
clone
identifi
xaxi
column
show
gmt
frnt
observ
differ
base
neutral
wild
type
virus
repres
genotyp
iii
iv
three
seven
virus
use
sequenc
final
thoma
et
al
use
previous
character
human
denv
sera
found
prnt
titer
significantli
affect
viru
strain
tissu
viru
propag
experi
strongli
hint
e
gene
depend
differ
polyclon
antibodi
neutral
directli
test
variabl
neutral
isogen
virus
encod
clearli
defin
e
gene
differ
late
convalesc
sera
result
significantli
advanc
pioneer
earli
studi
halstead
russel
well
recent
work
cite
collect
argu
antigen
variabl
genotyp
significantli
influenc
intraserotyp
neutral
respons
vitro
assay
panel
sera
e
variant
clone
found
dramat
larg
differ
frnt
valu
frnt
titer
low
homotyp
sera
text
data
indic
variat
e
strongli
drive
phenotyp
viral
protein
isogen
prospect
studi
denv
transmiss
found
low
titer
preexist
neutral
ab
prnt
endem
area
uniformli
protect
homotyp
infect
prospect
studi
matern
antibodi
newborn
found
neutral
titer
often
protect
homolog
viru
strain
even
endem
set
final
recent
human
challeng
studi
vaccin
subject
found
prnt
titer
one
vaccin
volunt
partial
protect
anoth
volunt
develop
fever
viremia
preexist
titer
current
vaccin
trial
defin
neutral
titer
evid
immun
potenti
lower
hypothes
protect
threshold
suggest
studi
cite
recent
vaccin
studi
durbin
et
al
guy
et
al
begun
test
vaccine
sera
repres
genotyp
howev
durbin
et
al
use
earli
convalesc
sera
day
post
vaccin
like
broadli
neutral
earli
postvaccin
captur
durabl
longterm
antibodi
respons
guy
et
al
similarli
evalu
vaccin
vaccin
sera
denv
genotyp
variant
use
primat
rather
human
sera
author
specifi
sampl
collect
post
vaccin
magnitud
neutral
differ
report
may
enough
lead
partial
protect
loss
protect
vaccin
depend
infect
genotyp
also
possibl
context
live
viru
vaccin
broad
within
serotyp
protect
confer
even
low
titer
antibodi
genotyp
differ
matter
context
protect
said
genotyp
iv
stand
experi
rel
nonreact
homotyp
human
immun
sera
figur
rais
question
whether
vaccin
could
potenti
creat
immunolog
nich
human
host
could
exploit
sylvat
geograph
genet
distant
genotyp
within
serotyp
find
serv
point
departur
studi
import
epitop
human
antibodi
respons
denv
infect
yet
defin
clone
select
alter
antigen
cluster
distribut
across
e
text
facilit
initi
map
epitop
respons
differenti
neutral
ideal
identifi
key
neutral
epitop
human
polyclon
immun
respons
turn
inform
ration
vaccin
possibl
therapeut
monoclon
antibodi
design
optim
epitop
elicit
potent
neutral
antibodi
although
specul
molecular
clone
may
also
prove
invalu
identifi
epitop
antibodi
respons
enhanc
dengu
infect
text
support
tabl
figur
docx
